Hydroxyectoine: nature-inspired skin calming active ingredient
Hydroxyectoine is a bio-based, high-purity active ingredient derived from halophilic microorganisms, designed to enhance skin hydration and resilience. It is ideal for use in wipes, liners, and barrier formulations, especially for reducing diaper rash in infants.
Overview
Hydroxyectoine is a naturally derived cyclic amino acid produced by halophilic microorganisms. It functions by creating a unique hydration shell that stabilizes macromolecules, preserving lipid organization and reducing irritation triggers. As an osmoprotectant, hydroxyectoine is designed to enhance skin hydration, resilience, and comfort, making it an ideal ingredient for baby care products such as wipes, liners, and barrier formulations. Its ability to address diaper rash drivers like moisture, heat, and barrier disruption offers a gentle, effective solution to maintain healthy skin in infants.
Technical specifications
- Composition: Naturally derived cyclic amino acid from halophilic microorganisms
- Production: Sustainable bio-fermentation via ectABC + ectD pathway
- Features: Stabilizes proteins, lipids, and cell junctions to maintain barrier integrity
- Applications: Suitable for wipes, liners, creams, and barrier formulations
- Benefits: Enhances hydration, reduces transepidermal water loss, and prevents irritation without pharmacological action
- Sustainability: Fully biodegradable and bio-based
Technology readiness level
Hydroxyectoine is at Technology Readiness Level 7, having been validated in clinical studies for sensitive and pediatric skin. It is ready for integration into large-scale baby care product formulations, with ongoing efforts to scale fermentation-based production for commercial volumes.
About Anomaly Bio
Anomaly Bio is a Singapore-based biotechnology company that utilizes synthetic biology, advanced fermentation, and strain engineering to produce bio-based ingredients. By designing optimized metabolic pathways, the company engineers microorganisms to transform readily available feedstocks, such as sugars, into high-value molecules. This approach turns microbes into efficient micro-factories, offering a scalable and on-demand alternative to traditional, extraction-based manufacturing methods. The company focuses on developing next-generation inputs for industries including crop protection, nutrition, and personal care.
By replacing fragile, legacy supply chains with localized and resilient biomanufacturing capabilities, Anomaly Bio aims to redefine the production of essential ingredients. This technology provides a viable, sustainable manufacturing solution that can be deployed globally to support various trade networks. The company has secured significant pre-seed funding to expand its R&D team in metabolic engineering and to establish its own laboratory and pilot-scale production facilities in Singapore.
delivered to your inbox.